Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China
· Delayed Price · Currency is CNY 24.72
-0.25 (-1.00%)
At close: Mar 9, 2026
SHE:002287 Revenue
In the year 2025, Tibet Cheezheng Tibetan Medicine had annual revenue of 2.42B CNY with 3.34% growth. Tibet Cheezheng Tibetan Medicine had revenue of 893.07M in the quarter ending December 31, 2025, with 3.10% growth.
Revenue
2.42B
Revenue Growth
+3.34%
P/S Ratio
5.83
Revenue / Employee
762.15K
Employees
3,170
Market Cap
14.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.42B | 78.04M | 3.34% |
| Dec 31, 2024 | 2.34B | 292.82M | 14.32% |
| Dec 31, 2023 | 2.05B | 363.07K | 0.02% |
| Jan 1, 2023 | 2.04B | 274.30M | 15.49% |
| Jan 1, 2022 | 1.77B | 285.43M | 19.22% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 1.47B |
| Mabwell (Shanghai) Bioscience | 662.52M |
| Inner Mongolia Furui Medical Science | 1.47B |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 16.62B |
| Anhui Anke Biotechnology (Group) | 2.58B |
| Jinyu Bio-technology | 1.33B |
| InventisBio | 37.33M |